Clinical Trials at the Summit 2023: Choosing right metrics and avoiding bias in clinical trials to prevent waste

Article

Ramin Tadayoni, MD, PhD, considers factors for choosing the right metrics and avoiding bias in clinical trials to prevent waste.

Ramin Tadayoni, MD, PhD, uses diabetic retinopathy as an example to illustrate choosing the right metrics and avoiding bias in clinical trials to prevent waste with Sheryl Stevenson, group editorial director, during the Clinical Trials at the Summit meeting on June 10, 2023, in Park City, Utah. Tadayoni is professor of ophthalmology, head of department, at the Université de Paris in France.

Video transcript

Editor’s note: This transcript has been edited for clarity.

Related Videos
Video 4 - "Treating Geographic Atrophy in Patients with Concurrent Neovascular AMD"
Video 3 - "Managing a Patient with Bilateral Geographic Atrophy"
Video 2 - "FDA-approved Therapies for Geographic Atrophy"
Video 1 - "Geographic Atrophy: Overview, Diagnosis, and Progression"
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
© 2024 MJH Life Sciences

All rights reserved.